OpenLegislation

The Misuse of Drugs Act 1971 (Modification) Order 1990

S.I. 1990/2589 · Made 19 December 1990

Original text. legislation.gov.uk does not revise statutory instruments, so later amendments are not shown here. Changes made to it are listed under each provision when known.

DANGEROUS DRUGS

Made 19th December 1990

Coming into operation 1st February 1991

At the Court at Buckingham Palace, the 19th day of December 1990

Present,

The Queen’s Most Excellent Majesty in Council

Whereas a draft of this Order has been laid before Parliament on the recommendation of the Advisory Council on the Misuse of Drugs and has been approved by a resolution of each House of Parliament:

Now, therefore, Her Majesty, in pursuance of section 2(2) of the Misuse of Drugs Act 1971f1, is pleased, by and with the advice of Her Privy Council, to order, and it is hereby ordered, as follows:

Annotations to the whole text

Footnotes

f1

1971 c. 38.

Contents

  1. 1Article 1
  2. 2Article 2
  3. Signature
  4. Explanatory note

1

This Order may be cited as the Misuse of Drugs Act 1971 (Modification) Order 1990 and shall come into force on 1st February 1991.

2

Schedule 2 to the Misuse of Drugs Act 1971 (which, as amendedf1, specifies the drugs which are subject to control under that Act) shall be amended by the insertion —

(a)

in paragraph 1 of Part I of that Schedule —

(i)

after the word “2,5-Dimethoxy-α,4-dimethylphenethylamine”, of the word “N-Hydroxy-tenamphetamine”, and

(ii)

after the word “2-Methyl-3-morpholino-1,1-diphenylpropanecarboxylic acid”, of the word “4-Methyl-aminorex”;

(b)

in paragraph 1 of Part III of that Schedule, after the word “Methyprylone”, of the word “Midazolam”.

Signature

G. I. de Deney

Clerk of the Privy Council

Explanatory note

(This note is not part of the Order)

This Order adds to Part 1 of Schedule 2 to the Misuse of Drugs Act 1971 (which specifies the Class A drugs which are subject to control under the Act) N-Hydroxy-tenamphetamine and 4-Methyl-aminorex. The Order also adds to Part III of that Schedule (which specifies the Class C drugs which are subject to such control) Midazolam.